Sophia Genetics - Multiplikator nilai perusahaan marang pendapatan SOPH

SOPHiA GENETICS SA (SOPH) is building an international community of medical centers for data exchange and is collaborating with pharmaceutical behemoths in the field of personalized therapy. The cloud architecture for genomic analysis relies on an extensive network of global laboratories. The EV/Revenue multiple demonstrates business resilience, while 5892.49 records a new level. The stability of recurring payments is ensured by the global diversification of subscription-based clients.
Sophia Genetics - rincian analitis lan metrik utama (SOPH)

To find fundamental support for SOPHiA GENETICS SA (SOPH), it is essential to evaluate the efficiency of data monetization. High customer retention within the genomics IT ecosystem ensures a stable cash flow. The enterprise value-to-revenue ratio measures the market price of the business regardless of debt load, reflecting the cost of every dollar of sales. The trend of this indicator shows the extent to which the market is willing to pay a premium for technological leadership. A stable trend confirms the high reliability of the asset.